Funicular Fund, LP - May 23, 2022 Form 4 Insider Report for ARCA biopharma, Inc. (ABIO)

Role: Other*
Signature: Funicular Fund, LP, By: Cable Car Capital LLC, its general partner, By: /s/ Jacob Ma-Weaver, Managing Member
Stock symbol: ABIO
Transactions as of: May 23, 2022
Transactions value $: $197,404
Form type: 4
Date filed: 5/25/2022, 05:12 PM
Previous filing: May 20, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABIO	Common Stock	Purchase	$5.28K	+2.3K	+0.09%	$2.30	2.5M	May 23, 2022	Direct	F1, F2
transaction	ABIO	Common Stock	Purchase	$41.4K	+18.1K	+0.73%	$2.29	2.52M	May 24, 2022	Direct	F1, F2, F3
transaction	ABIO	Common Stock	Purchase	$151K	+64.9K	+2.58%	$2.32	2.58M	May 25, 2022	Direct	F1, F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ABIO	Put Option (obligation to buy)						14.5K	May 23, 2022	Common Stock	1.45M	$2.50	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This Form 4 is filed by the Funicular Fund, LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
F2	Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.
F3	Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2850 to $2.2950, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.
F4	Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.2550 to $2.3450, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.